Noriomi Matsumura - Gynecology

Author Information

Noriomi Matsumura is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at Kindai University Faculty of Medicine, located in Osakasayama, Osaka, Japan. His extensive work primarily focuses on gynecologic oncology, addressing various critical aspects of cancer treatment and outcomes.

Research Contributions

Noriomi Matsumura has made significant contributions to the field of gynecology, particularly in oncology. His research spans critical areas such as the effectiveness of the human papillomavirus vaccine, the role of immunosuppressive tumor microenvironments, and the individualization of first-line treatments for advanced ovarian cancer. His studies also delve into the intricate mechanisms of molecularly targeted drugs and the genetic underpinnings of various cancers, enhancing our understanding of germline variants and their implications in oncology.

Aliases

N. Matsumura, Noriomi Matsumura

Publication and Citation Metrics

Metric	Value
Citation Count	9220
h-index	44
Paper Count	309

Publications:

Oncologic outcomes in elderly patients who underwent hysterectomy for endometrial cancer: a multi-institutional survey in Kinki District, Japan

DOI: 10.1007/s10147-022-02152-6

Year: 2022

Individualization in the first-line treatment of advanced ovarian cancer based on the mechanism of action of molecularly targeted drugs

DOI: 10.1007/s10147-022-02163-3

Year: 2022

Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells.

DOI: 10.1093/carcin/bgac032

Year: 2022

Increasing our knowledge of germline variants

DOI: 10.1007/s13691-021-00529-4

Year: 2022

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women

DOI: 10.1111/cas.15270

Year: 2022

Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report.

DOI: 10.1177/10668969211069963

Year: 2022

The roles and limitations of bevacizumab in the treatment of ovarian cancer

DOI: 10.1007/s10147-022-02169-x

Year: 2022

Management Strategies for Brain Tumors Diagnosed during Pregnancy: A Case Report and Literature Review

DOI: 10.3390/medicina57060613

Year: 2021

A novel malignant peritoneal mesothelioma with STRN exon 2 and ALK exon 20 : a case report and literature review.

DOI: 10.1002/onco.13714

Year: 2021

Tertiary lymphoid structures induced by CXCL13-producing CD4+ T cells increase tumor infiltrating CD8+ T cells and B cells in ovarian cancer

DOI: 10.1101/2021.12.01.470493

Year: 2021

What measures can be taken for medication safety?

What Are Hormonal Creams?

What is Monsplasty?

What Are the Limitations of Mammograms?

What are Home Pregnancy Tests?

What is Folic Acid Deficiency?

What Diet and Lifestyle Choices Support Reproductive Health?

What Happens After Reaching the Out of Pocket Maximum?

What are the Common Imaging Techniques Involving Radiation?

How is Karyotyping Performed?

Partnered Content Networks

Relevant Topics